Related Experiment Video
Updated: Jun 23, 2025
Author Spotlight: Advancing Facial Rejuvenation Therapy with Post-Laser Salicylic Acid Application
Published on: September 27, 2024
Energy-Based Devices for the Treatment of Facial Skin Conditions in Skin of Color
Riana D Sanyal1, Sabrina G Fabi2
1Dr. Sanyal is with the Department of Dermatology, Kaiser Permanente Los Angeles Medical Center, Los Angeles, California and the Metropolis Dermatology, Los Angeles, California.
Background:
The development of microfocused ultrasound and fractional radiofrequency-based devices has expanded the range of cosmetic treatment options for patients with skin of color. Fractional non-ablative laser treatments can also be safely performed in skin types III-VI with appropriate settings and adjunctive topical treatments.
Objective:
We sought to review the available literature on the use of energy-based devices for treatment of facial skin conditions in skin types III-VI.
Methods:
A PubMed search was performed on studies from 2010-2021 assessing safety and efficacy of fractional ablative and non-ablative lasers, radiofrequency, and microfocused ultrasound-based treatments for conditions such as acne scars, melasma, benign pigmented lesions, rhytids, and skin laxity in skin types III-VI.
Results:
Seven randomized trials, fourteen prospective cohort studies, and six retrospective reviews were included. Combination treatment with fractional radiofrequency and non-ablative laser has demonstrated efficacy in the treatment of acne scars in skin of color with minimal adverse effects. Laser-assisted drug delivery with low-density 1927-nm thulium or diode lasers has been shown to reduce the number of treatments required for significant clearance of melasma as compared with other modalities. Microfocused ultrasound has been shown to safely treat skin laxity in skin of color.
Limitations:
There is a paucity of studies which include patients with skin type VI, limiting our overall understanding of the safety of these treatments in skin of color.
Conclusion:
There are numerous available studies demonstrating safety and efficacy of energy-based devices for the treatment of facial skin conditions in skin types III-VI, but the significant variation among their designs, methods of assessment, and study populations highlights the need for larger meta-analyses to further interpret their results.
